Recruiting at 2 sites No phase Osteoarthritis of the Shoulder

Osteoarthritis of the Shoulder study: Total Shoulder Arthroplasty

Official title TSA vs RSA in Glenohumeral Osteoarthritis

ClinicalTrials.gov ID: NCT04228419

What this study is testing

What it's testing
The trial aims to find out which surgery works best for older adults with shoulder arthritis and a specific shoulder bone angle.
Who it's for
Participants must be 65 years old or older, have shoulder osteoarthritis, and a glenoid retroversion of 15 degrees or less.
What's involved
Participants will be randomly assigned to receive either a total shoulder arthroplasty (TSA) or a reverse shoulder arthroplasty (RSA) and will attend scheduled follow‑up visits and tests to track recovery.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 65 and older

You may be able to join if

  • The use of drugs including analgesics and non-steroidal anti-inflammatory drugs
  • Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)
  • Activity modification
  • Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss
  • Patients may present with a glenoid deficiency and \</=15 degrees of retroversion

You likely can't join if

  • Active joint or systemic infection
  • Rotator cuff arthropathy
  • Significant muscle paralysis
  • Charcot's arthropathy
  • Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)
  • Unable to understand the consent form/process
See the full eligibility criteria
Who can join
  • The use of drugs including analgesics and non-steroidal anti-inflammatory drugs
  • Physiotherapy consisting of stretching, strengthening and local modalities (ultrasound, cryotherapy, etc.)
  • Activity modification
  • Imaging, and intra-operative findings confirming advanced glenohumeral cartilage loss
  • Patients may present with a glenoid deficiency and \</=15 degrees of retroversion
  • 65 years of age and older
What rules you out
  • Active joint or systemic infection
  • Rotator cuff arthropathy
  • Significant muscle paralysis
  • Charcot's arthropathy
  • Major medical illness (life expectancy less than 1 year or unacceptably high operative risk)
  • Unable to understand the consent form/process
  • Pregnancy
  • Psychiatric illness that precludes informed consent
  • Unwilling to be followed for the duration of the study
  • Retroversion cannot be surgically corrected to within 10 degrees of neutral
  • History of previous shoulder surgery on affected side

The study team makes the final eligibility decision.

Where it is enrolling

  • Kingston, Ontario, Canada
  • Ottawa, Ontario, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Kingston, Ontario, Canada; Ottawa, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.